Raquel Fernandez del Rio

Raquel Fernandez del Rio is a Researcher at the University of Birmingham, affiliated with the Birmingham Clinical Trials Unit. Her work focuses on identifying volatile biomarkers in exhaled breath for diagnosing and monitoring liver diseases like liver cirrhosis and hepatic encephalopathy, particularly through advanced analytical techniques such as PTR-MS. She has contributed to understanding how compounds like limonene and isoflurane correlate with liver conditions before and after transplantation.

Research Output

• 3 peer-reviewed articles (2015–2016) examining breath biomarkers in liver disease and post-operative anesthetic elimination.
• Active Co-Investigator in the IMPROVE DKD Trial (2024–2028), a government-funded project addressing diabetes and chronic kidney disease care in older populations.

Specializations

Her research sits at the intersection of clinical medicine, analytical chemistry, and respiratory diagnostics, emphasizing non-invasive methods for disease monitoring.